Glybenclamid (HB 419) and the prediabetes of subtotally pancreatectomized rats.
D000818:Animals; D000941:Antigens / Q000032:analysis; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D005951:Glucose Tolerance Test; D005905:Glyburide / Q000494:pharmacology; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D008297:Male; D008660:Metabolism / Q000187:drug effects; D010179:Pancreas / Q000503:physiopathology; D010180:Pancreatectomy; D011236:Prediabetic State / Q000378:metabolism*; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D013997:Time Factors
D000941:Antigens; D001786:Blood Glucose; D007328:Insulin; D013453:Sulfonylurea Compounds; D005905:Glyburide